American Society for Hematology (ASH) 2019 Annual Meeting: Our Recommended CAR T Cell Therapy Innovation Talks

CBPartners recommends the best 8 CAR T Cell Therapy Innovation Talks to attend at ASH 2019

The American Society of Hematology’s (ASH) annual meeting is a well-established indicator of the innovations that are coming down the pipeline for hematologic diseases. As this year’s meeting approaches (Dec 7-10), CBPartners’ experts from our Cell and Gene Therapy Center of Excellence have selected 8 promising presentations on the future…

Poster at ISPOR international on the role of indirect comparisons in the AMNOG evaluation procedure

The AMNOG assessment procedure requires that manufacturers submit indirect comparisons for the evaluation of molecules in the absence of the availability of direct comparisons versus the G-BA designated appropriate comparator(s). Although guidelines have been established on how indirect comparisons should be structured and carried out, the methodological robustness sought by…